Financhill
Buy
71

BEAM Quote, Financials, Valuation and Earnings

Last price:
$28.15
Seasonality move :
-3.39%
Day range:
$27.50 - $28.29
52-week range:
$13.53 - $35.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
47.43x
P/B ratio:
2.96x
Volume:
866.1K
Avg. volume:
1.9M
1-year change:
-2.33%
Market cap:
$2.9B
Revenue:
$63.5M
EPS (TTM):
-$4.43

Earnings Data

Next earnings date for BEAM
Feb 24
2026
Most recent earnings per share
-$1.10
Missed by $0.09
(Nov 4/2025)
Consensus Estimate
-$1.01
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BEAM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/24/2026 Q4 $13.5M -- -- -$1.12 --
11/04/2025 Q3 $12.7M $9.7M -$1.10 -$1.01 -$0.09
08/05/2025 Q2 $13.3M $8.5M -$1.00 -$1.09 $0.09
05/06/2025 Q1 $14.7M $7.5M -$1.24 -$1.17 -$0.07
02/25/2025 Q4 $16.5M $30.1M -$1.09 -$1.22 $0.12
11/05/2024 Q3 $14.1M $14.3M -$1.17 -$1.18 $0.01
08/06/2024 Q2 $13M $11.8M -$1.11 -$1.12 $0.01
05/07/2024 Q1 $14.7M $7.4M -$1.21 -$1.39 $0.18
02/27/2024 Q4 $33.7M $316.2M $1.73 -$0.71 $2.44
11/08/2023 Q3 -- $17.2M -$1.22 -- --
08/08/2023 Q2 -- $20.1M -$1.08 -- --
05/10/2023 Q1 -- $24.2M -$1.33 -- --
02/28/2023 Q4 -- $20M -$0.54 -- --
11/07/2022 Q3 -- $15.8M -$1.56 -- --
08/09/2022 Q2 -- $16.7M -$1.02 -- --
05/09/2022 Q1 -- $8.4M -$1.01 -- --
02/28/2022 Q4 -- $51.1M -$0.95 -- --
11/08/2021 Q3 -- $763K -$0.42 -- --
08/10/2021 Q2 -- $6K -$1.23 -- --
05/11/2021 Q1 -- $6K -$3.35 -- --
03/30/2021 Q4 -- $6K -$1.69 -- --
11/10/2020 Q3 -- $6K -$0.69 -- --
08/12/2020 Q2 -- $6K -$0.69 -- --
05/12/2020 Q1 -- $6K -$1.03 -- --
03/30/2020 Q4 -- $6K -$0.61 -- --
09/30/2019 Q3 -- $6K -$0.43 -- --
06/30/2019 Q2 -- $6K -$0.41 -- --
03/31/2019 Q1 -- -- -$0.32 -- --
12/31/2018 Q4 -- -- -$0.51 -- --
09/30/2018 Q3 -- -- -$1.37 -- --

Beam Therapeutics, Inc. Earnings Questions

  • How Much did Beam Therapeutics, Inc. Generate in Revenue Last Quarter?

    Beam Therapeutics, Inc. reported $9.7M worth of top line sales in its most recent quarter.

  • Did Beam Therapeutics, Inc. Beat Earnings Last Quarter?

    Beam Therapeutics, Inc. announced earnings per share of -$1.10 which represents a miss of analyst forecast a -$1.01 per share.

  • Is Beam Therapeutics, Inc. Profitable?

    Beam Therapeutics, Inc. reported $4.1M that represents $0.04 per share over the last quarter.

  • What is the Analyst Consensus for Beam Therapeutics, Inc. EPS Next Year?

    Beam Therapeutics, Inc.'s earnings are forecast to decrease from -$4.58 per share to -$4.68 per share next year representing a decrease of -4.17%.

  • When is Beam Therapeutics, Inc.'s Earnings Date?

    Beam Therapeutics, Inc.'s next earnings date is February 24, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock